Zheng, Y., Wang, Z., Ding, X., Dong, Y., Zhang, W., Zhang, W., . . . Song, X. (2017). Combined Erlotinib and PF‐03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma. Cell Prolif.
Dyfyniad Arddull ChicagoZheng, Yang, et al. "Combined Erlotinib and PF‐03084014 Treatment Contributes to Synthetic Lethality in Head and Neck Squamous Cell Carcinoma." Cell Prolif 2017.
Dyfyniad MLAZheng, Yang, et al. "Combined Erlotinib and PF‐03084014 Treatment Contributes to Synthetic Lethality in Head and Neck Squamous Cell Carcinoma." Cell Prolif 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.